Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson specialty Surgery [reported separately through FY2019Q4] — U.S. operational growth YoY (%) (%)
Form 8-K EX-99.2 Segment Sales Schedule
Latest, FY2019
-40.1%
Period ended Dec 29, 2019
Change on a year earlier
-37.4 pts
-2.7% in FY2018
History
3 years
Since FY2017
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Specialty Surgery [reported separately through FY2019Q4] — U.S. operational growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2019 | Dec 29, 2019 | -40.1% | -37.4 pts | Form 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗ |
| FY2018 | Dec 30, 2018 | -2.7% | +8.8 pts | Form 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗ |
| FY2017 | Dec 31, 2017 | -11.5% | – | Form 8-K (a8k2017q4exhibit9915.htm, filed 2018-01-23) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson Specialty Surgery [reported separately through FY2019Q4] — U.S. operational growth YoY (%) (%), annual FY2017–FY2019 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/mt_surg_specialty_us_ops_yoy
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.